DMG Productions discovers the latest breakthroughs in cardiovascular disease research and treatment.
Jupiter, FL— Innovations with Ed Begley Jr. announced today that it will feature Detroit R&D in an upcoming episode, airing third quarter 2016 via Discovery Channel. Dates and show times TBA.
Detroit R&D (DRD) is an NIH SBIR-sponsored company that specializes in the development and manufacture of ELISA, antibodies and assay kits for research, diagnosis and treatment of cardiovascular disease and cancer.
This segment will explore Detroit R&D’s efforts on development and commercialization of diagnostic hypertension ELISA kits (soon-to-be FDA-registered, BioTarget® clinical ELISAs) to solve problems of fast growing number of patients with full-blown high blood pressure which results in heart and kidney failures and stroke (the number of deaths from hypertension-related diseases has increased 61.8% from 2000 to 2013).
Hypertension affects nearly 50 million individuals in the USA and about 1 billion people worldwide but is an under-diagnosed condition because the underlying damage to the body occurs with only mild or no symptoms. Unfortunately, the cause of hypertension has been unknown in about 90 percent of reported cases. Use of the BioTarget® ELISA kits, which measure hypertension biomarkers, will reform the current approach of “trial and error” treatment (administering one to four of ~75 existing medications to see which one works).
Audiences will also learn about the opportunity to ameliorate coronary heart disease, insulin resistance and type-2 diabetes by targeted treatment of the P450 and soluble EH-dependent hypertension.
“Detroit R&D is making waves in the research, diagnosis and treatment of cardiovascular diseases and diabetes,” said Michele Nehls, Senior Producer for the series. “We look forward to enlightening the public on these amazing advances coming to light.”
About Detroit R&D:
Founded in 1997 by Dr. Hyesook Kim, Detroit R&D has been steadily establishing itself as a worldwide source for novel diagnostic and drug-screening products. The Detroit R&D laboratories and offices are located in the heart of a new redevelopment district in the city of Detroit, Michigan. Detroit R&D with an original project to develop easy and inexpensive hypertension kits for measuring novel fatty acid biomarkers in blood, urine and tissue has evolved to a company with leading-edge technologies in the fields of hypertension, stroke, cardiovascular diseases and diabetes (verified by >50 peer-reviewed publications by end-users). Detroit R&D also developed prostate, breast and lung cancer biomarker kits and other products including mitochondrial DNA damage, site-specific glycosylation antibodies and oxidative stress (8-isoprostane) and environmental estrogen (BPA) ELISAs.
For more information, visit: www.detroitrandd.com or contact Marketing Director Dave Putt at 313-961-1606 or via email at [email protected].
About Innovations and DMG Productions:
Innovations, hosted by award winning actor Ed Begley, Jr., is an information-based series geared toward educating the public on the latest breakthroughs in all areas of society. Featuring practical solutions and important issues facing consumers and professionals alike, Innovations focuses on cutting-edge advancements in everything from health and wellness to global business, renewable energy, and more.
DMG Productions (responsible for creating the Innovations show) includes personnel specialized in various fields from agriculture to medicine, independent films to regional news and more. Field producers work closely with experts in the field to develop stories. This powerful force enables DMG to consistently produce commercial-free, educational programming that both viewers and networks depend on.
For more information visit: www.InnovationsTelevision.com or contact Michele Nehls at (866) 496-4065 x 822 or via email at [email protected].
Leave a Reply